attenuated the decreases in mRNA levels for HSPG (P<0.01) in glomeruli of PAN-injected rats. Enalapril Background. We previously reported that mRNA levels for extracellular matrix ( ECM) components had little eÂect on increased glomerular mRNA levels for MMP-2 and TIMP-1 in PAN nephrosis, whereas and endothelin (ET )-1 are upregulated in glomeruli of puromycin aminonucleoside (PAN ) nephrosis. FR139317 attenuated the increases in glomerular mRNA levels for MMP-2 (P<0.01) and TIMP-1 Angiotensin-converting enzyme (ACE ) inhibitors are eÂective in experimental models of renal injury, includ-(P<0.01).
investigators have reported that an ET receptor A Preparation and quantification of glomerular RNA antagonist, FR139317, attenuated renal injuries in a Total cellular RNA was extracted from the isolated glomeruli remnant kidney model or lupus mice [6, 7] . of each rat with RNA zol BA (Cinna/Biotecx Laboratories, The rat model of puromycin aminonucleoside Inc., Houston, TX ). Total glomerular RNA was denatured ( PAN ) nephrosis is an established model of minimal-with formamide and formaldehyde, electrophoresed through change glomerular disease. Previously we reported that a 1% agarose gel (20 mg RNA/lane) containing 2.2 M the glomerular mRNA for ECM components is altered formaldehyde/0.2 M MOPS ( pH 7.0) transferred to a nylon in PAN nephrosis, and that methylprednisolone membrane (Gene Screen, New England Nuclear, Boston, ( MPSL) has marked eÂects on the amelioration of MA) overnight by capillary blotting in 10×SSPE (1×SSPE=0.18 M, NaCl, 0.01 M NaH 2 PO 4 , 0.001 M abnormal gene expression in glomeruli of rats with EDTA) , and baked at 80°C for 2 h. Examination of the PAN nephrosis [8] . However, to our knowledge there membrane under ultraviolet light in the presence of ethidium are no reports concerning the eÂects of either bromide demonstrated good resolution and integrity of the FR139317 or enalapril on gene expression for the 28S and 18S ribosomal bands. ECM components, metalloproteinases (MMP), tissue inhibitor of metalloproteinase ( TIMP)-1 or ET-1. In this study we examined the eÂects of FR139317 and cDNA probes and hybridization conditions enalapril on the gene expression of the ECM components, MMP-1, -2 and -3, TIMP-1 and ET-1 in the The cDNA probes used for Northern blot analysis were as follows: clones for the a1 ( IV ) collagen chain (pFAC ) and glomeruli of PAN-injected rats.
laminin B1 (p24 ) and B2 (p7) chains were isolated from a cDNA library constructed from diÂerentiated F9 teratocarcinoma cell mRNA, as reported previously [ 9] . Rat a1 (I) (paR1) and a1 ( III) ( 1. 
Animals
(Bethesda, MD) [10, 11] . Rat MMP-1 and MMP-3 cDNA probes were provided by Dr Lynn M. Matrisian of Vanderbilt The subjects consisted of 90 male Sprague-Dawley rats University ( Nashville, TN ) [12 ] . Human MMP-2 cDNA was (weighing 150-200 g) that were housed in individual metaprovided by Dr Gregory I. Goldberg of Washington bolic cages, and daily urine volume, water intake, body University School of Medicine (St Louis, MO) [13] . Human weight, blood pressure, and urinary protein were measured TIMP-1 cDNA was provided by Dr Masanobu Naruto of throughout the experiments. The diet included 22.0% protein, Basic Research Laboratories, Toray Industries ( Kanagawa, 3.5% fat, 0.4% sodium, 1.0% calcium, and 0.88% phosphate. Japan). Rat prepro-ET-1 cDNA was provided by Dr Tomoh A single dose (15 mg/100 g body weight) of puromycin Masaki of Kyoto University ( Kyoto, Japan) [14] . Rat aminonucleoside (Sigma Chemical Co., St Louis, MO) was GAPDH cDNA was obtained from the American Tissue injected intraperitoneally into 45 rats to induce a nephrotic Type Culture collection (Rockville, MD). All probes state; the remaining 45 rats were used as controls. The were labelled with [a-32P]-deoxycytidine 5-triphosphate animals were divided into six groups ( 15 rats in each group). (3000 Ci/mmol ) from NEN Research Products ( Tokyo, Group 1 consisted of PAN-injected rats given no treatment. Japan) by random primer extension. In group 2, PAN-injected rats were given enalapril 35 mg/l Membranes were prehybridized in a solution containing ( Merck, Rahway, NJ) in their drinking water. In group 3, 50% foramide, 5×SSPE, 5×Denhards, 0.1% SDS and 100 mg PAN-injected rats were given an intraperitoneal injection of of salmon sperm DNA per ml. Hybridization was performed the specific ET receptor A antagonist, FR139317 ( Fujisawa, (using the same solution to which 1×109 c.p.m./ml of 32P-Osaka, Japan) [6, 7] at a dose of 3.2 mg/100 g every day for labelled cDNA was added) for 24 h at 65°C. Blots were then 20 days. Group 4 consisted of saline-injected rats given no washed three times in 2×SSPE, 0.1% SDS at 65°C for treatment. In group 5, saline-injected rats were given enalapril 10 min and then in 0.1×SSPE, 0.1% SDS for cDNA probes in their drinking water. In group 6, saline-injected rats were at 65°C for 10 min. After drying, membranes were exposed given FR139317 for 20 days. All drugs were administered to Kodak X-OMAT-AR film ( Eastman Kodak, Rochester, from the time of disease induction (on day 0 ). The food NY ) at −80°C with intensifying screens for periods of 12 h ingested by PAN-treated rats was weighted daily and the to 7 days. The relative intensities of bands on the autoradiogsame amount of food was given to control rats.
rams were quantified on a Scanning Shimadzu CS-9000 Five rats from each group were killed on days 0, 8, and densitometer (Shimadzu Manufacturing, Kyoto, Japan). 20. The kidneys were removed immediately, and the glomeruli Membranes were rehybridized with additional probes. were isolated by sieving through size 60, 150, and 200 meshes. Decapsulated glomeruli were collected from the top of the 200-mesh sieve. The purity of the preparation of decapsulated Quantitation of mRNA glomeruli was greater than 95% and contained very few tubular fragments.
The RNA from five rats was randomly pooled and three During the course of the experiments, 24-h urine specimens Northern blots were performed per group (=15 animals). were obtained from all rats in metabolic cages daily; urinary Densitometry readings were normalized for equivalent protein was measured using the biuret method. Serum total amounts of GAPDH per lane. Values were expressed as protein, creatinine, and urea were measured by standard optical density units relative to the specific mRNA levels laboratory methods. Blood pressure was measured in observed in glomerular RNA from untreated control rats (group 4 ). unanaesthetized rats by indirect tail cuÂ plethysmography.
Statistical analysis
enalapril nor FR139317 aÂected urinary protein excretion in control rats (groups 5 and 6 ). (Table 2 ). The Values were expressed as means±standard error. diminution of the proteinuria was observed in the first Comparisons between two time points in the same animals 5 days of the treatment with enalapril or FR139317.
or between groups paired were made using the paired t test for parametric data or Wilcoxon signed-ranks test for nonGlomerular mRNA analysis parametric data. Non-parametric data from multiple groups were tested using the Kruskall-Wallis test followed by In group 1, mRNA levels for a1 (IV ) collagen chain, Mann-Whitney U test. Parametric data from multiple groups laminin B1 and B2 chains, MMP-2, TIMP-1 and ET-1 were compared using one-way analysis of variance increased significantly when compared with control ( ANOVA).
rats (group 4 ) on day 8 and then declined to the control level by day 20 (on day 8: a1 (IV ), 2.6-fold (P<0.01); laminin B1, 2.4-fold (P<0.01); laminin B2, Results 2.6-fold (P<0.01); MMP-2, 2.2-fold (P<0.01); TIMP-1, 2.6-fold (P<0.01) and ET-1, 2.3-fold Biochemical data (P<0.01)). However, mRNA levels for a1 ( I ) and a1 Food intake was 10.2±2.2 g, 11.4±1.4 g and (III ) collagen chains, MMP-1 and MMP-3 showed 11.6±1.2 g on days 0, 8, 20 respectively in PAN-little change throughout the experimental period, treated rats (group 1 ). Food consumption was almost whereas those for heparan sulphate proteoglycan identical in all groups of rats since the same amount (HSPG ) decreased significantly when compared with of food ingested by nephrotic rats was given to control control rats (group 4 ) on day 8 (0.5-fold, P<0.01) rats. Biochemical data and renal functions on day 8 and then increased to the control level by day 20. are shown in Table 1 . The body weights of control and Enalapril attenuated the increased mRNA levels for nephrotic rats were not diÂerent on any day. Both a1 (IV ) collagen chain, laminin B1 and B2 chains and enalapril and FR139317 did not influence body weight ET-1 in glomeruli of PAN-injected rats (on day 8; a1 in nephrotic and control rats. Blood pressure of control (IV ), 0.5-fold (P<0.01); laminin B1, 0.6-fold and nephrotic rats was not diÂerent on any day. Both (P<0.01); laminin B2, 0.5-fold (P<0.01); and ET-1, enalapril and FR139317 did not influence blood pres-0.5-fold (P<0.01)) when compared with mRNA levels sure in both groups. There was a significant rise in in group 1. In addition, enalapril attenuated the serum creatinine and urea in PAN-treated rats. This decreased mRNA levels for HSPG (1.5-fold, P<0.01) rise was reduced by either enalapril or FR139317. on day 8 in glomeruli of PAN-injected rats. However, Because nephrotic rats drink 1.5 times more water enalapril did not alter mRNA levels of MMP-2 and than control rats, nephrotic rats received 1.5 times TIMP-1 in glomeruli of PAN-injected rats. Enalapril enalapril (real dose: group 2, 1 mg/24 h, group 5, 0.7 mg/24 h).
Urinary protein excretion
In group 1, rats developed proteinuria within 4 days after PAN injection. Proteinuria was highest on day 8 ( 268±20 mg/day) and then declined to the control level by day 20. In group 2, enalapril significantly (P<0.001) suppressed urinary protein (68±10 mg/day on day 8 ). In group 3, FR139317 suppressed urinary protein (110±14 mg/day on day 8 ) (P<0.001). In group 4, urinary protein remained less than 20 mg/day throughout the experimental period (20 days). Neither did not aÂect mRNA levels of a1 (I ) and a1 (III ) [3, 4, 7] . The beneficial eÂect of ACE inhibitors was collagen chains, MMP-1, MMP-3 and GAPDH in associated with an improved permeability of the glomglomeruli of PAN-injected rats. erular membrane for water and macromolecules based FR139317 attenuated the increased mRNA levels on a mechanism possibly mediated by a reduction in for a1 ( IV ) collagen chain ( 0.5-fold, P<0.01), laminin the mean radius of large and unselective pores that B1 (0.6-fold, P<0.01), laminin B2 (0.5-fold, P<0.01), perforate the glomerular capillary. Remuzzi et al. [15] MMP-2 (0.5-fold, P<0.01), TIMP-1 ( 0.5-fold, reported that an ACE inhibitor, despite only partially P<0.01) and ET-1 (0.5-fold, P<0.01) and the controlling systemic blood pressure, eÂectively predecreased mRNA levels for HSPG (1.6-fold, P<0.01) vented proteinuria and glomerular injury and that a in glomeruli of PAN-injected rats on day 8. FR139317 calcium-channel blocker was not associated with renal did not aÂect mRNA levels of a1 (I ) and a1 ( III ) protection. ACE inhibitors may ameliorate glomerular collagen chains, MMP-1, MMP-3 and GAPDH in microcirculation by a mechanism that is not directly glomeruli of PAN-injected rats. Figure 1 shows the related to their antihypertensive action. It was also Northern blot analysis of mRNA for all components suggested that ACE inhibitors have a direct eÂect on on day 8 in groups 1-3. Neither enalapril nor the structural/functional properties of the glomerular FR139317 aÂected mRNA levels for any of these basement membrane [15] . This is consistent with the components in glomeruli of control rats (groups 5 and present study which found that enalapril modulates 6 ). Table 3 shows the relative changes in these mRNAs the ECM composition. Klahr et al. [16, 17] have in groups 1-6 on day 8 after PAN or saline injection. reported that enalapril reduces the increased synthesis of ECM components in the obstructed kidney and Discussion suggested that enalapril may aÂect the balance between production and degradation of ECM components. We previously reported that both enalapril and
The protective eÂect of ACE inhibitors on renal FR139317 prevent renal injuries in animal models function is always associated with a remarkably improved glomerular barrier permeability to proteins [18] . HSPG is thought to play an important role in the permselective properties of the glomerular capillary wall. In the present study we showed that enalapril attenuated the decreased HSPG mRNA in the glomeruli of PAN-injected rats. The mechanisms involved in the enalapril eÂect could be related to glomerular haemodynamics or to a direct inhibition of the mitogenic eÂect of angiotensin II. Angiotensin II has a direct hypertrophic and hyperplastic action on several types of cells (including glomerular cells) [19, 20] and may cause glomerular hypertrophy, an important factor in the induction of glomerular injury [21] . Angiotensin II also stimulates the synthesis of ECM components in mesangial cells [22] . This may be directly involved in glomerular injury, promoting the modulation of ECM components. Therefore, our data may indicate that enalapril reduces the mRNA expression of a1 (IV ) collagen chain and laminin chains via the reduction of angiotensin II activity. The early eÂect of captopril on proteinuria is largely a reflection of its well-known ability to inhibit kinase activity and augment the local level of bradykinin. Tanaka et al. [23] reported that early-phase proteinuria of puromycin aminonucleoside nephrosis is independent of angiotensin II and that the antiproteinuric eÂect of ACE inhibitors is, at least in part, channelled In the present study we showed that glomerular through a 0.7% agarose gel containing formaldehyde, then transmRNA levels for MMP-2 and TIMP-1 are increased ferred to Genescreen filters. Filters were hybridized with specific on day 8 at the peak of proteinuria in PAN nephrosis, cDNA probes as described in Subjects and methods. Five animals whereas those of MMP-1 and MMP-3 are unchanged were used in each group and three Northern blots were prepared. One representative experiment is shown.
throughout the experimental period. The relative Table 3 . Glomerular mRNA analysis (fold-increase) on day 8 expression of TIMP versus MMP in the glomeruli may increase in ET-1 gene expression in mesangial cells.
ET receptor B mediates the autostimulation of ET-1 be critical in modulating the balance between the maintenance and destruction of the ECM in renal production and may amplify the adverse eÂects mediated by this peptide. A non-selective ET antagonist diseases, including PAN nephrosis. We showed that enalapril has no eÂect on the gene expression of that binds both the ET receptor A and B reduced blood pressure and urinary protein excretion in the MMP-2 and TIMP-1 in the glomeruli of PAN nephrosis. We previously reported that enalapril has models of renal mass ablation [27] . Further studies would be needed to determine whether ET receptor B no eÂect on decreased mRNA levels of MMP-1 and MMP-3 or increased mRNA levels for TIMP-1 in antagonist modulates the gene expression of ECM components, MMPs and TIMP-1 in the glomeruli of diabetic glomeruli [4 ] .
Endothelin ( ET )-1 is a potential mediator of renal PAN-injected rats.
In summary, our data demonstrated that enalapril damage. Remuzzi et al. [2] reported that an ACE inhibitor, lisinopril, significantly reduced urinary excre-attenuates increases in mRNA levels for a1 (IV ) collagen chain, laminin chains, ET-1 and decreases in tion of ET-1 in nephrectomized rats. Firth et al. [24 ] reported that an ACE inhibitor, ramipril, reduced the mRNA levels for HSPG in glomeruli of PAN-injected rats but does not aÂect changes in MMP-2 and TIMP-1 elevation of ET-1 mRNA in the clipped kidney. In the present study we showed that enalapril reduced the mRNA expression. In addition we demonstrated that FR139317 attenuated the changes of glomerular elevation of ET-1 mRNA in the glomeruli of PAN-injected rats. The mechanisms of the specific mRNA for all components mentioned above. The gene regulation of ECM components may be diÂerent from suppressing eÂect of the ACE inhibitors on renal ET-1 formation must remain speculative at the moment.
that of MMP/TIMP in PAN nephrosis. In addition we showed that an ET receptor A antagonist, FR139317, reduced the elevation of a1 in the rat is exerted through binding with its ET cDNAs encoding for the a1 (I), a1 ( III ), and a1 (IV ) collagen receptor A, since blood pressure remained normal in chains, laminin B1 and B2 chains, and HSPG. We thank Dr L.M. all animals with or without PAN injection during the Matrisian ( Vanderbilt University, Nashville, TN) for providing the
